Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
PEPG Stock News and Mentions of PepGen Inc. Stocktwits
Updated: April 29, 2024 (10:08)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where PepGen Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of PepGen Inc. (PEPG).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the PepGen stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of PepGen Inc. (PEPG)
April 25, 2024 (14:00) / "Zacks Commentary" (by Zacks Equity Research)
Best Momentum Stocks to Buy for April 25th
TXO, PEPG and ERO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 25, 2024.
In Article Trend: Neutral
April 25, 2024 (10:52) / "Zacks Commentary" (by Zacks Equity Research)
New Strong Buy Stocks for April 25th
TAK, TXO, PEPG, ERO and RMNI have been added to the Zacks Rank #1 (Strong Buy) List on April 25, 2024.
In Article Trend: Neutral
April 10, 2024 (12:47) / "Business Insider" (by Avi Kapoor)
Insiders Buying GameStop And 2 Other Stocks
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
In Article Trend: Somewhat-Bullish
April 10, 2024 (12:11) / "Benzinga" (by Avi Kapoor)
Insiders Buying GameStop And 2 Other Stocks - GameStop ( NYSE:GME )
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
In Article Trend: Somewhat-Bullish
March 13, 2024 (20:05) / "GlobeNewswire" (by PepGen Inc.)
PepGen to Participate in Upcoming Investor Conferences
BOSTON, March 13, 2024 ( GLOBE NEWSWIRE ) -- PepGen Inc. ( Nasdaq: PEPG ) , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that ...
In Article Trend: Neutral
March 13, 2024 (11:00) / "GlobeNewswire" (by PepGen Inc.)
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
BOSTON, March 13, 2024 ( GLOBE NEWSWIRE ) -- PepGen Inc. ( Nasdaq: PEPG ) , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that the ...
In Article Trend: Neutral
March 13, 2024 (11:00) / "Benzinga" (by Globe Newswire)
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy - PepGen ( NASDAQ:PEPG )
BOSTON, March 13, 2024 ( GLOBE NEWSWIRE ) -- PepGen Inc. PEPG, a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that the U.S.
In Article Trend: Neutral
March 12, 2024 (13:55) / "Zacks Commentary" (by Zacks Equity Research)
Can PepGen, Inc. ( PEPG ) Climb 48.62% to Reach the Level Wall Street Analysts Expect?
The mean of analysts' price targets for PepGen, Inc. (PEPG) points to a 48.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
In Article Trend: Somewhat-Bullish
March 11, 2024 (16:00) / "Zacks Commentary" (by Zacks Equity Research)
PepGen, Inc. ( PEPG ) Upgraded to Buy: What Does It Mean for the Stock?
PepGen, Inc. (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website